A. Eden Evins | Psychiatrist.com

Article

Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials

Original Research

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

Original Research

Bupropion Sustained Release Added to Group Support for Smoking Cessation in Schizophrenia: A New Randomized Trial and a Meta-Analysis

Original Research

Change in Cognition With Sustained Cannabis Abstinence

Regular cannabis use during adolescence has been linked to cognitive impairments. To what degree does abstaining from cannabis lead to cognitive improvements in adolescents and young adults who otherwise...

Original Research

Clozapine, Diabetes Mellitus, Hyperlipidemia, and Cardiovascular Risks and Mortality: Results of a 10-Year Naturalistic Study

Article

The Effect of Marijuana Use on the Risk for Schizophrenia

Article

Efficacy of Newer Anticonvulsant Medications in Bipolar Spectrum Mood Disorders

Original Research

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

Original Research

Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis

Original Research

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

Original Research

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

Original Research

Modafinil for Clozapine-Treated Schizophrenia Patients: A Double-Blind, Placebo-Controlled Pilot Trial

Original Research

Predictors of Early Abstinence in Smokers With Schizophrenia

Article

A Randomized, Double-Blind, Placebo-Controlled Trial of Long-Acting Risperidone in Cocaine-Dependent Men

Original Research

Smoking Cessation in Patients With Psychiatric Disorders

Letter to the Editor

Varenicline Treatment for Smokers With Schizophrenia: A Case Series

Original Research

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

Article

Commentary: Smoking Cessation in Patients With Psychiatric Disorders

Educational Activity

Does Using Marijuana Increase the Risk for Developing Schizophrenia?